Literature DB >> 9651149

5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors.

J D Albright1, M F Reich, E G Delos Santos, J P Dusza, F W Sum, A M Venkatesan, J Coupet, P S Chan, X Ru, H Mazandarani, T Bailey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651149     DOI: 10.1021/jm980179c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  18 in total

1.  Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.

Authors:  S Nakamura; Y Yamamura; S Itoh; T Hirano; K Tsujimae; M Aoyama; K Kondo; H Ogawa; T Shinohara; K Kan; Y Tanada; S Teramoto; T Sumida; S Nakayama; K Sekiguchi; T Kambe; G Tsujimoto; T Mori; M Tominaga
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

3.  Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.

Authors:  Josefa Ros; Guillermo Fernández-Varo; Javier Muñoz-Luque; Vicente Arroyo; Juan Rodés; Joseph W Gunnet; Keith T Demarest; Wladimiro Jiménez
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 4.  Vaptans for the treatment of hyponatremia.

Authors:  Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-02-01       Impact factor: 43.330

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

Authors:  J P Morello; A Salahpour; A Laperrière; V Bernier; M F Arthus; M Lonergan; U Petäjä-Repo; S Angers; D Morin; D G Bichet; M Bouvier
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  5-Dichloro-acetyl-4-methyl-2,3,4,5-tetra-hydro-1H-1,5-benzodiazepin-2-one hemihydrate.

Authors:  K Ravichandran; P Sakthivel; S Ponnuswamy; M Shalini; M N Ponnuswamy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-26

8.  2-[2-(4-Methoxyphenyl)-2,3-dihydro-1H-1,5-benzodiazepin-4-yl]phenol.

Authors:  Yvon Bibila Mayaya Bisseyou; Ané Adjou; Yapi Marcellin Yapo; Guy Euloge Bany; R C A Kakou-Yao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-09

9.  4-Methyl-2-oxo-2,3,4,5-tetra-hydro-1H-1,5-benzodiazepine-5-carbaldehyde.

Authors:  K Ravichandran; P Sakthivel; S Ponnuswamy; P Ramesh; M N Ponnuswamy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-05

Review 10.  Pharmacology of vasopressin antagonists.

Authors:  Lisa C Costello-Boerrigter; Guido Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2008-09-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.